ESVS外周动脉疾病与慢性肢体威胁性缺血指南中女性代表性与性别分层报告评估
本研究评估ESVS 2024 PAD指南和2019 CLTI全球血管指南推荐所依据研究中女性的纳入与报告情况。在213项PAD和116项CLTI研究中,仅21%和约10%报告性别分层数据,女性在约64%和约55%研究中纳入不足。结论认为女性在指南证据中代表性和报告均不足。
要点
- PAD和CLTI指南证据中仅21%和约10%研究报告性别分层数据
- 女性在约64%的PAD和约55%的CLTI研究中纳入不足
- 女性第一作者与性别分层报告几率增加相关
核心结论
- 女性在ESVS PAD和CLTI指南所依据的证据中代表性和报告均不足。
- 未来学会指南应基于性别均衡纳入和一致性别特异性报告的研究。
研究设计与样本
- 研究方案在PROSPERO注册(CRD42024559537),按PRISMA Equity指南执行,使用RStudio分析。
- 提取ESVS 2024 PAD指南和2019 CLTI全球血管指南推荐陈述所依据的所有研究数据。
- 共分析213项PAD研究和116项CLTI研究,其余参考文献为共识文件或单性别人群等被排除。
主要发现
- 仅21%的PAD研究和约10%的CLTI研究报告性别分层数据。
- 仅10%的PAD研究和2%的CLTI研究报告性别分层主要结局。
- 参与者性别未报告在约42%的PAD研究和约39%的CLTI研究中。
- 女性在约64%的PAD研究和约55%的CLTI研究中纳入不足(PPR<0.8)。
- 多国研究、女性作者比例较高和证据等级较强与更好的女性纳入相关;女性第一作者与性别分层报告几率增加相关。
关键数值与推荐
- 纳入不足定义为参与患病率比(PPR)<0.8。
- 采用二元逻辑回归评估性别分层结局报告相关因素,加权线性回归评估PPR增加相关因素。
临床怎么用
- 临床医生应意识到PAD和CLTI指南证据中女性数据常缺失或报告不足。
- 在解读和应用指南推荐时需考虑性别代表性不足可能影响女性患者的外推性。
- 未来研究应确保性别均衡纳入并常规报告性别分层结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to evaluate the extent to which women are represented and reported within the scientific evidence supporting the clinical practice guidelines on peripheral arterial disease (PAD) and chronic limb threatening ischaemia (CLTI). DATA SOURCES: Data were extracted from all studies supporting recommendation statements within the European Society for Vascular Surgery (ESVS) 2024 clinical practice guidelines on the management of PAD and the 2019 global vascular guidelines on the management of CLTI, including study type, journal impact factor, year of publication, country, sex of authors, participant sex, use of a sex stratified main outcome, and sex disaggregated reporting. REVIEW METHODS: The protocol was registered with PROSPERO (CRD42024559537) and conducted in accordance with PRISMA Equity guidelines. Analyses were performed using RStudio. Under enrolment was defined as a participation prevalence ratio (PPR) < 0.8. Binary logistic regression evaluated factors associated with reporting sex stratified outcomes; weighted linear regression assessed factors linked to increased PPR. RESULTS: Of 89 PAD and 113 CLTI recommendations, 213 and 116 unique studies were analysed. The remaining references were consensus documents or were excluded for reasons such as single sex populations. Only 21% and ∼10% of the studies reported sex disaggregated data, while only 10% and 2% reported sex stratified outcomes in PAD and CLTI, respectively. Participants' sex was unreported in ∼42% (PAD) and ∼39% (CLTI). Women were under enrolled in ∼64% (PAD) and ∼55% (CLTI) of studies. Multinational studies, higher proportion of women authors, and stronger evidence levels were associated with better women's enrolment. Women first authorship was associated with increased odds of sex stratified reporting. Other factors that influenced sex stratified reporting included more women participants, a higher proportion of women authors, and recent publication year. CONCLUSION: Women are under represented and under reported in the evidence underpinning ESVS PAD and CLTI guidelines. Future societal guidelines should be based on research with balanced inclusion and consistent sex specific reporting.
引用
- Hamo N, Pouncey AL, Chandra V, et al. Evaluation of Sex Specific Representation and Sex Disaggregated Reporting in the European Society for Vascular Surgery Clinical Practice Guidelines on the Management of Peripheral Arterial Disease and Chronic Limb Threatening Ischaemia. Eur J Vasc Endovasc Surg. 2026. PMID: 42462864. doi:10.1016/j.ejvs.2026.07.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。